Ricardo Rocha

Advised a wide range of pharmaceutical companies on regulatory matters, including marketing authorisations for medicinal products, approval of medical devices and innovative products, pricing and reimbursement (price setting and review), market access, co-payments, clinical trials, prior assessment agreements and early access programmes, as well as litigation and administrative offence proceedings;

Advised and assisted clients in market access procedures for medicinal products, in particular in the definition of pricing and reimbursement for procurement by the National Health Service;

Advised on regulatory matters relating to other health products, including veterinary medicines, food supplements and cosmetics;

Advised pharmaceutical companies on the drafting and negotiation of commercial agreements, including Co-Marketing Agreements, Licensing Agreements, contracts with Contract Manufacturing Organisations (CMOs), Distribution Agreements, contracts with Contract Research Organisations (CROs) and supply agreements;

Provided ongoing legal and regulatory advice to the leading Portuguese wholesaler of medicines, medical devices and other health products, covering day-to-day activities, new projects and compliance with regulatory obligations;

Advised companies on the import, export, manufacture and distribution of cannabis-based products for medicinal purposes, including regulatory and corporate matters;

Advised on the regulation of medicines, health products and healthcare services from the perspective of community pharmacies, including the creation of new healthcare services, the modernisation of existing services and the preparation of regulatory measures and proposals relating to the commercialisation of medicines, health products and healthcare services;

Advised a leading healthcare sector company on the design and launch of new pharmaceutical and primary healthcare services to be provided in the majority of community pharmacies in Portugal.